CA1016456A - Stabilized mycoplasma vaccine - Google Patents

Stabilized mycoplasma vaccine

Info

Publication number
CA1016456A
CA1016456A CA180,347A CA180347A CA1016456A CA 1016456 A CA1016456 A CA 1016456A CA 180347 A CA180347 A CA 180347A CA 1016456 A CA1016456 A CA 1016456A
Authority
CA
Canada
Prior art keywords
stabilized
mycoplasma vaccine
mycoplasma
vaccine
stabilized mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA180,347A
Other languages
English (en)
Other versions
CA180347S (en
Inventor
Morimasa Yoshioka
Eizo Hayatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitasato University
Original Assignee
Kitasato University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato University filed Critical Kitasato University
Application granted granted Critical
Publication of CA1016456A publication Critical patent/CA1016456A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA180,347A 1972-10-05 1973-09-05 Stabilized mycoplasma vaccine Expired CA1016456A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10002872A JPS5540568B2 (da) 1972-10-05 1972-10-05

Publications (1)

Publication Number Publication Date
CA1016456A true CA1016456A (en) 1977-08-30

Family

ID=14263067

Family Applications (1)

Application Number Title Priority Date Filing Date
CA180,347A Expired CA1016456A (en) 1972-10-05 1973-09-05 Stabilized mycoplasma vaccine

Country Status (12)

Country Link
US (1) US3917819A (da)
JP (1) JPS5540568B2 (da)
AU (1) AU461928B2 (da)
BE (1) BE805570A (da)
CA (1) CA1016456A (da)
DE (1) DE2348897C3 (da)
FR (1) FR2201878B1 (da)
GB (1) GB1439407A (da)
IL (1) IL43310A (da)
IT (1) IT1055538B (da)
NL (1) NL159584B (da)
SU (1) SU625623A3 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60197628A (ja) * 1984-03-22 1985-10-07 Eisai Co Ltd マイコプラズマ性肺炎予防治療剤
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US5004607A (en) * 1987-08-25 1991-04-02 University Of Georgia Research Foundation, Inc. Method of immunizing poultry
ES2058237T3 (es) * 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
DE69027112T2 (de) * 1989-01-23 1997-01-09 Auspharm International Ltd 4Th Impfstoffzusammensetzung
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
FR2722509B1 (fr) * 1994-07-15 1996-09-20 Pasteur Institut Identification de genes codant pour des proteines ayant une activite d'esterase dans differentes souches de mycoplasma mycoides
CA2184132C (en) * 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
MX362166B (es) 2012-03-07 2018-12-14 Ceva Sante Animale Nueva vacuna veterinaria.
BR112015003074A2 (pt) * 2012-08-17 2017-07-04 Intervet Int Bv composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético.
HUE059179T2 (hu) * 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
PT2938747T (pt) * 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
AU2013370982C9 (en) * 2012-12-28 2019-01-24 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
CN103479995B (zh) * 2013-10-08 2015-04-15 南京天邦生物科技有限公司 鸡毒支原体、鸡滑液囊支原体二联灭活疫苗的制备方法
CN103495160B (zh) * 2013-10-08 2015-11-18 南京天邦生物科技有限公司 鸡滑液囊支原体灭活疫苗的制备方法
CN104324370B (zh) * 2014-09-30 2019-12-20 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1074920A (en) * 1965-04-21 1967-07-05 Pfizer & Co C Growth medium for mycoplasma pneumoniae and vaccine production

Also Published As

Publication number Publication date
DE2348897C3 (de) 1980-02-14
GB1439407A (en) 1976-06-16
NL7313052A (da) 1974-04-09
JPS4955822A (da) 1974-05-30
FR2201878B1 (da) 1977-11-04
DE2348897B2 (de) 1979-06-21
DE2348897A1 (de) 1974-09-26
US3917819A (en) 1975-11-04
AU461928B2 (en) 1975-06-12
FR2201878A1 (da) 1974-05-03
NL159584B (nl) 1979-03-15
IT1055538B (it) 1982-01-11
SU625623A3 (ru) 1978-09-25
IL43310A (en) 1978-01-31
JPS5540568B2 (da) 1980-10-18
IL43310A0 (en) 1973-11-28
AU6021373A (en) 1975-03-13
BE805570A (fr) 1974-02-01

Similar Documents

Publication Publication Date Title
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU459336B2 (en) Indoanilines
AU454372B2 (en) Childsafe actuator-overcap
CA970706A (en) Plural-cell duct
AU472078B2 (en) Emulsion
AU466344B2 (en) Cycloalkyllactamimides
AU475577B2 (en) Stabilized methychloroform
AU451635B2 (en) Vaccine preparation
AU469666B2 (en) C-aminoalkyl-4-hydroxy-3 alkylsulfonylmethybenzyl alcohols
AU475431B2 (en) Benzodioxan derivatives
AU467526B2 (en) Pyronorifamycins
AU458822B2 (en) Headgear structure
AU468601B2 (en) Emulsion
AU456127B2 (en) Benzodioxan derivatives
AU471191B2 (en) BICYCLIC-N-HETEROCYCLIC alcohols
AU478476B2 (en) Improved rollerskate
AU465942B2 (en) Buhner
AU460536B2 (en) Triazolobenzophenones
AU464772B2 (en) 5-aroyl-2-(tetrazol-2-ylmethyl) -pyrroles
AU451103B2 (en) 1-alkylidene-3-indenyl echanols
AU4575372A (en) 2-acyl-5-nitrothiazoles
CA905848A (en) Vaccines
CA907042A (en) Polysiloxanes
CA857299A (en) Vaccines